- Home
- GOCO vs EVAX Comparison
GOCO vs EVAX Comparison
Compare GOCO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOCO | EVAX |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 33.4M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GOCO | EVAX |
|---|---|---|
| Price | $1.76 | $3.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $5.00 | ★ $12.33 |
| AVG Volume (30 Days) | 37.9K | ★ 78.6K |
| Earning Date | 02-26-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $738,338,000.00 | $7,650,000.00 |
| Revenue This Year | N/A | $128.77 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.56 | ★ 132.17 |
| 52 Week Low | $1.83 | $1.20 |
| 52 Week High | $21.00 | $12.15 |
Technical Indicators
Market Signals| Indicator | GOCO | EVAX |
|---|---|---|
| Relative Strength Index (RSI) | 32.47 | 35.73 |
| Support Level | $1.83 | $2.87 |
| Resistance Level | $2.10 | $3.66 |
| Average True Range (ATR) | 0.16 | 0.34 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 1.35 | 27.68 |
Price Performance
Historical ComparisonAbout GOCO GoHealth Inc.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.